Cancer therapy resistance remains a major obstacle to successful treatment, contributing to disease recurrence and poor ...

Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...